Prostate-specific antigen doubling time predicts clinical outcome and survival in prostate cancer patients treated with combined radiation and hormone therapy (Q81801781)
Jump to navigation
Jump to search
scientific article published on 01 October 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | Prostate-specific antigen doubling time predicts clinical outcome and survival in prostate cancer patients treated with combined radiation and hormone therapy |
scientific article published on 01 October 2005 |
Statements
Prostate-specific antigen doubling time predicts clinical outcome and survival in prostate cancer patients treated with combined radiation and hormone therapy (English)
Deborah Kuban
Andrew K Lee